Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.
| Μορφή: | Βιβλίο |
|---|---|
| Γλώσσα: | English |
| Έκδοση: |
Geneva :
World Health Organization,
2001.
|
| Θέματα: |
MARC
| LEADER | 00000nam a2200000 u 4500 | ||
|---|---|---|---|
| 001 | 1190 | ||
| 003 | GR-PADA | ||
| 005 | 20230803141859.0 | ||
| 008 | 130912s2001 en af||e b eng d | ||
| 020 | |a 9173920637 | ||
| 040 | |a GrATPDL |d ΕΘΝΙΚΗ ΣΧΟΛΗ ΔΗΜΟΣΙΑΣ ΥΓΕΙΑΣ-ΚΕΝΤΡΙΚΗ ΒΙΒΛΙΟΘΗΚΗ |c ΠΑΝΕΠΙΣΤΗΜΙΟΥΠΟΛΗ ΑΘΗΝΩΝ | ||
| 041 | 0 | |a eng | |
| 082 | |a 362.1969792 | ||
| 245 | 0 | 0 | |a Guidelines for using HIV testing technologies in surveillance : |b selection, evaluation and implementation. |
| 260 | |a Geneva : |b World Health Organization, |c 2001. | ||
| 300 | |a 38 σ. : |b εικ., πίν. ; |c 30 εκ. | ||
| 504 | |a Βιβλιογραφία: σ. 37-38. | ||
| 650 | 0 | |a Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας. |9 879 | |
| 650 | 0 | |a Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV) |9 3882 | |
| 650 | 0 | |a AIDS (Disease) |9 880 | |
| 650 | 0 | |a HIV. |9 3883 | |
| 942 | |2 ddc |c BK |h 362.1969792 GUI |6 362_196979200000000_GUI | ||
| 952 | |0 0 |1 0 |2 ddc |4 0 |6 362_196979200000000_GUI |7 1 |9 2001 |a MAIN |b MAIN |d 2020-01-10 |l 0 |o 362.1969792 GUI |p 00001429 |r 2020-01-10 |t 1 |w 2020-01-10 |y BK | ||
| 999 | |c 1659 |d 1659 | ||
Εγγραφή στο Ευρετήριο Αναζήτησης
| _version_ | 1784614217442131968 |
|---|---|
| building | Campus Library III |
| collection | LIB3 Catalog |
| dewey-full | 362.1969792 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.1969792 |
| dewey-search | 362.1969792 |
| dewey-sort | 3362.1969792 |
| dewey-tens | 360 - Social problems and services; associations |
| format | Book |
| fullrecord | {"leader":"01183nam a2200253 u 4500","fields":[{"001":"1190"},{"003":"GR-PADA"},{"005":"20230803141859.0"},{"008":"130912s2001 en af||e b eng d"},{"020":{"subfields":[{"a":"9173920637"}],"ind1":" ","ind2":" "}},{"040":{"subfields":[{"a":"GrATPDL"},{"d":"\u0395\u0398\u039d\u0399\u039a\u0397 \u03a3\u03a7\u039f\u039b\u0397 \u0394\u0397\u039c\u039f\u03a3\u0399\u0391\u03a3 \u03a5\u0393\u0395\u0399\u0391\u03a3-\u039a\u0395\u039d\u03a4\u03a1\u0399\u039a\u0397 \u0392\u0399\u0392\u039b\u0399\u039f\u0398\u0397\u039a\u0397"},{"c":"\u03a0\u0391\u039d\u0395\u03a0\u0399\u03a3\u03a4\u0397\u039c\u0399\u039f\u03a5\u03a0\u039f\u039b\u0397 \u0391\u0398\u0397\u039d\u03a9\u039d"}],"ind1":" ","ind2":" "}},{"041":{"subfields":[{"a":"eng"}],"ind1":"0","ind2":" "}},{"082":{"subfields":[{"a":"362.1969792"}],"ind1":" ","ind2":" "}},{"245":{"subfields":[{"a":"Guidelines for using HIV testing technologies in surveillance :"},{"b":"selection, evaluation and implementation."}],"ind1":"0","ind2":"0"}},{"260":{"subfields":[{"a":"Geneva :"},{"b":"World Health Organization,"},{"c":"2001."}],"ind1":" ","ind2":" "}},{"300":{"subfields":[{"a":"38 \u03c3. :"},{"b":"\u03b5\u03b9\u03ba., \u03c0\u03af\u03bd. ;"},{"c":"30 \u03b5\u03ba."}],"ind1":" ","ind2":" "}},{"504":{"subfields":[{"a":"\u0392\u03b9\u03b2\u03bb\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03af\u03b1: \u03c3. 37-38."}],"ind1":" ","ind2":" "}},{"650":{"subfields":[{"a":"\u03a3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf \u03b5\u03c0\u03af\u03ba\u03c4\u03b7\u03c4\u03b7\u03c2 \u03b1\u03bd\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae\u03c2 \u03b1\u03bd\u03b5\u03c0\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1\u03c2."},{"9":"879"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"\u0399\u03cc\u03c2 \u03c4\u03b7\u03c2 \u03b1\u03bd\u03b8\u03c1\u03ce\u03c0\u03b9\u03bd\u03b7\u03c2 \u03b1\u03bd\u03bf\u03c3\u03bf\u03b1\u03bd\u03b5\u03c0\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1\u03c2 (HIV)"},{"9":"3882"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"AIDS (Disease)"},{"9":"880"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"HIV."},{"9":"3883"}],"ind1":" ","ind2":"0"}},{"942":{"subfields":[{"2":"ddc"},{"c":"BK"},{"h":"362.1969792 GUI"},{"6":"362_196979200000000_GUI"}],"ind1":" ","ind2":" "}},{"952":{"subfields":[{"0":"0"},{"1":"0"},{"2":"ddc"},{"4":"0"},{"6":"362_196979200000000_GUI"},{"7":"1"},{"9":"2001"},{"a":"MAIN"},{"b":"MAIN"},{"d":"2020-01-10"},{"l":"0"},{"o":"362.1969792 GUI"},{"p":"00001429"},{"r":"2020-01-10"},{"t":"1"},{"w":"2020-01-10"},{"y":"BK"}],"ind1":" ","ind2":" "}},{"999":{"subfields":[{"c":"1659"},{"d":"1659"}],"ind1":" ","ind2":" "}}]}
|
| id | lib3_1659 |
| illustrated | Illustrated |
| institution | University of West Attica |
| isbn | 9173920637 |
| language | English |
| physical | 38 σ. : εικ., πίν. ; 30 εκ. |
| publishDate | 2001 |
| publisher | World Health Organization, |
| record_format | marc |
| spelling | Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation. Geneva : World Health Organization, 2001. 38 σ. : εικ., πίν. ; 30 εκ. Βιβλιογραφία: σ. 37-38. Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας. 879 Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV) 3882 AIDS (Disease) 880 HIV. 3883 |
| spellingShingle | Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation. Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας. 879 Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV) 3882 AIDS (Disease) 880 HIV. 3883 |
| title | Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation. |
| title_auth | Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation. |
| title_full | Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation. |
| title_fullStr | Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation. |
| title_full_unstemmed | Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation. |
| title_short | Guidelines for using HIV testing technologies in surveillance : |
| title_sort | guidelines for using hiv testing technologies in surveillance selection evaluation and implementation |
| title_sub | selection, evaluation and implementation. |
| topic | Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας. 879 Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV) 3882 AIDS (Disease) 880 HIV. 3883 |
| topic_facet | Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας. Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV) AIDS (Disease) HIV. |